郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

肿瘤模型ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models.

期刊:PloS one发表年份:2020作者:Amanda Hanson; Kutlu Elpek; Ellen Duong; Lindsey Shallberg; Martin Fan; Calvin Johnson; Matthew Wallace; George R Mabry; Stephen Sazinsky; Lauren Pepper; Chengyi J Shu; Sriram Sathyanarayanan; Sarah Zuerndorfer; Tyler Simpson; Monica Gostissa; Michae

肿瘤模型In Vivo Validation of the BIANCA Biophysical Model: Benchmarking against Rat Spinal Cord RBE Data.

期刊:International journal of molecular sciences发表年份:2020作者:Mario P Carante; Giulia Aricò; Alfredo Ferrari; Christian P Karger; Wioletta Kozlowska; Andrea Mairani; Paola Sala; Francesca Ballarini

肿瘤模型Discovery, expression, cellular localization, and molecular properties of a novel, alternative spliced HP1γ isoform, lacking the chromoshadow domain.

期刊:PloS one发表年份:2020作者:Angela Mathison; Thiago Milech De Assuncao; Nikita R Dsouza; Monique Williams; Michael T Zimmermann; Raul Urrutia; Gwen Lomberk

肿瘤模型Synthesis and in vitro characterization of the genotoxic, mutagenic and cell-transforming potential of nitrosylated heme.

期刊:Archives of toxicology发表年份:2020作者:Tina Kostka; Jörg Fohrer; Claudia Guigas; Karlis Briviba; Nina Seiwert; Jörg Fahrer; Pablo Steinberg; Michael T Empl